(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ANDOVER EYE INSTITUTE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ANDOVER EYE INSTITUTE

ST13

US500000098593465

Class

35, 42

Filing

98593465

Registration

8044835

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

11/26/2025

Trademark type

Word

Nice classes

35, 42

Filing date

06/10/2024

Registration date

11/25/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/25/2025

Last transaction

11/26/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

06/22/2024

First use in commerce

06/22/2024

Drawing code

4

Owner type

03

Owner location

Andover, MA

Examiner

EMILO,LORI ANNE

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Andover Eye Associates, Inc.

Representatives

Michael R Rizzo Saunders & Silverstein LLP

Technical classification

Nice Classes

Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; compilation and analysis of biostatistics for business or commercial purposes

Class 42

Medical and scientific researchconducting clinical trials for others; pharmaceutical drug development services; pharmaceutical testing services

Publications

History of USPTO decisions and trademark events.

22 publications found

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/25/2025

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

11/25/2025

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

10/24/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/23/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/23/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/23/2025

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

07/23/2025

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

07/23/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/23/2025

GNRT

NON-FINAL ACTION E-MAILED

04/23/2025

CNRT

NON-FINAL ACTION WRITTEN

04/23/2025

IUAA

USE AMENDMENT ACCEPTED

04/17/2025

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

03/27/2025

IUAF

USE AMENDMENT FILED

03/27/2025

EAAU

TEAS AMENDMENT OF USE RECEIVED

03/27/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/27/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/28/2024

GNRT

NON-FINAL ACTION E-MAILED

12/28/2024

CNRT

NON-FINAL ACTION WRITTEN

12/28/2024

DOCK

ASSIGNED TO EXAMINER

12/27/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/26/2024

NWAP

NEW APPLICATION ENTERED

06/10/2024

Continuous trademark protection

Get notified about every new filing that threatens ANDOVER EYE INSTITUTE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.